Altre lingue Novo Nordisk A/S

Azioni

NOVO B

DK0062498333

Prodotti farmaceutici

Tempo reale stimato Cboe Europe Altri mercati azionari 10:55:56 19/02/2026			Variaz. 5gg	Var. 1 gen.
309,22 ^DKK	-0,67%		+1,03%	-4,78%

09:26	Novo Nordisk: Pronti i sostituti di Ozempic e Wegovy alla scadenza dei brevetti - Berlingske	FW
18/02	Arla, produttore di Lurpak, prevede prezzi lattiero-caseari più bassi e crescita dai prodotti proteici	RE

Altre lingue

07:21	NHS must keep medicine clawback down or lose investment, says Novo Nordisk boss
18/02	Lurpak-maker Arla sees lower dairy prices and boost from protein products
18/02	EMEA Morning Briefing : Markets Await Fed Minutes
18/02	Health Care Down as Deal Activity Offsets Mixed Earnings -- Health Care Roundup
17/02	Novo Holdings dissolves share stake in Recursion Pharmaceuticals
17/02	Europese beurzen houden goed stand
17/02	Die große KI-Neubewertung
17/02	European Stocks Advance in Tuesday Trading; German Inflation Rises to 2.1%
17/02	Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasible
17/02	Dr. Reddy's Looks to Launch Generic Wegovy at 60% Discount
17/02	La UE aprueba una dosis más alta del medicamento contra la obesidad de Novo Nordisk
17/02	Dr. Reddy's Looks to Launch Generic Wegovy at 60% Discount, Reuters Reports
17/02	Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable
17/02	Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable
17/02	Novo Nordisk-L'UE approuve une hausse du dosage du Wegovy
17/02	Novo Nordisk Wins EU Approval for Higher Dose of Weight-loss Drug Wegovy
17/02	Novo Nordisk : Höhere Dosis für Abnehmspritze Wegovy in EU zugelassen
17/02	Novo Nordisk's Wegovy Weight Loss Shot Approved at Higher Dose in EU
17/02	EU approves higher dose of Novo Nordisk's Wegovy
17/02	European Commission approves more effective dose of Novo Nordisk's injectable Wegovy for adults
17/02	Novo Nordisk A/S: The European Commission approves more effective dose of injectable Wegovy® for adults with obesity; clinical study showed people lost about 21% of their body weight on average
17/02	The European Commission Approves More Effective Dose of Injectable Wegovy® for Adults with Obesity; Clinical Study Showed People Lost About 21% of Their Body Weight on Average
17/02	The Great AI Repricing
17/02	Dr Reddy's aims to launch generic obesity drug at 60% discount
17/02	Lilly apunta a India como centro de exportación ante auge de ventas de Mounjaro, dice ejecutivo